Mesoblast (MESO) Deferred Taxes (2016 - 2023)
Mesoblast (MESO) reported Deferred Taxes of -$46000.0 for Q1 2023, down 2.22% on a YoY basis from -$47045.5 in Q1 2022, and up 35.21% sequentially from -$71000.0 in Q4 2022.
Mesoblast (MESO) Deferred Taxes (2016 - 2023) Analysis & Trends
Mesoblast (MESO) has 8 years of Deferred Taxes data on file, last reported at -$46000.0 in Q1 2023.
- For the quarter ending Q1 2023, Deferred Taxes fell 2.22% year-over-year to -$46000.0; the trailing twelve-month figure through Mar 2023 stood at -$220000.0 (down 94.69% YoY), and the FY2022 full-year result was -$235000.0, up 71.31% from the prior year.
- Deferred Taxes climbed to -$46000.0 in Q1 2023, from -$71000.0 in the prior quarter.
- In the past five years, Deferred Taxes ranged from a high of $74000.0 in Q4 2020 to a low of -$2.3 million in Q4 2019.
- A 5-year average of -$478636.4 and a median of -$62000.0 in 2021 frame the typical range for Deferred Taxes.
- Across the five-year window, Deferred Taxes jumped 103.26% in 2020 and tumbled 208.11% in 2021, its largest moves.
- Tracing MESO's Deferred Taxes over 5 years: stood at -$2.3 million in 2019, then soared by 103.26% to $74000.0 in 2020, then plunged by 208.11% to -$80000.0 in 2021, then grew by 11.25% to -$71000.0 in 2022, then jumped by 35.21% to -$46000.0 in 2023.
- Business Quant data shows MESO's Deferred Taxes at -$46000.0 in Q1 2023, -$71000.0 in Q4 2022, and -$55000.0 in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -859,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -65.30 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 96.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Mesoblast | 19.81 Bn | 19.68 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | -46,000.00 |
| Dec 31, 2022 | -71,000.00 |
| Sep 30, 2022 | -55,000.00 |
| Jun 30, 2022 | -48,000.00 |
| Mar 31, 2022 | -45,000.00 |
| Dec 31, 2021 | -80,000.00 |
| Sep 30, 2021 | -62,000.00 |
| Dec 31, 2020 | 74,000.00 |
| Sep 30, 2020 | -730,000.00 |
| Dec 31, 2019 | -2.27 Mn |
| Sep 30, 2019 | -1.93 Mn |
| Sep 30, 2018 | -711,000.00 |
| Jun 30, 2018 | -1.02 Mn |
| Mar 31, 2018 | -3.38 Mn |
| Dec 31, 2017 | -23.36 Mn |
| Sep 30, 2017 | -2.90 Mn |
| Jun 30, 2017 | -4.08 Mn |
| Mar 31, 2017 | -3.09 Mn |
| Dec 31, 2016 | -3.13 Mn |
| Sep 30, 2016 | -3.11 Mn |